Biosafety lab sued by watchdog

A nuclear watchdog group filed a federal lawsuit on Monday (March 10) to suspend work at a Biosafety Level 3 lab at the Lawrence Livermore National Laboratory, which opened to little fanfare earlier this year and conducts research on pathogens such as Ebola, anthrax and Q fever. The suit, filed by linkurl:Tri-Valley CAREs,;http://www.trivalleycares.org/pressRelease/prmar08.asp a Livermore-based community group that monitors nuclear weapons and environmental cleanup activities locally and nation

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A nuclear watchdog group filed a federal lawsuit on Monday (March 10) to suspend work at a Biosafety Level 3 lab at the Lawrence Livermore National Laboratory, which opened to little fanfare earlier this year and conducts research on pathogens such as Ebola, anthrax and Q fever. The suit, filed by linkurl:Tri-Valley CAREs,;http://www.trivalleycares.org/pressRelease/prmar08.asp a Livermore-based community group that monitors nuclear weapons and environmental cleanup activities locally and nationally, charges that the Department of Energy should have conducted a full environmental impact assessment before opening the pathogen research lab, and did not hold the necessary public comment sessions. "We have agreed to a schedule for resolution of the motion for preliminary injunction in an effort to avoid the potential expense of resources to address a temporary restraining order. This agreement will also allow the court to decide the issue as expeditiously as possible. The U.S. Department of Justice will file a response to the lawsuit on our behalf by March 26, 2008," the DOE said in a statement Emailed to The Scientist. According to a court document Emailed to The Scientist by John Belluardo, a DOE spokesman, the lab will refrain from animal experiments, genetically modifying BSL-3 pathogens, testing aerosolized pathogens, or storing more than 100 ml of BSL-3 pathogens for 60 days, while the court reviews the motion. Marylia Kelly, the executive director of Tri-Valley CAREs, said that one of the group's main concerns is that the pathogens to be studied at the lab, which are associated with bio-warfare, make the facility a potential target for terrorist attack. She also cited problems in Livermore's safety record, noting a $450,000 linkurl:fine;http://www.the-scientist.com/blog/display/54350/ the institution received last year for irregularities in shipping anthrax. Kelly added that conducting research on pathogens that could be used as bioweapons at Lawrence Livermore, which also conducts classified work on nuclear weapons, threatens enforcement of the international Biological Weapons Convention because the facility is not open to inspections. Tri-Valley CAREs first sued the DOE and Lawrence Livermore in 2003, and won a 2006 lawsuit in which the court ruled that the DOE must re-examine the threat of terrorist attack on the lab. The DOE concluded in that review that the lab posed no significant threat; the group contested that finding, and claims it was not made available for public comment as required by law.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform